Impact of extending direct antiviral agents (DAA) availability in France: an observational cohort study (2015-2019) of data from French administrative healthcare databases (SNDS).-Reference-Cited by-同舟云学术

Impact of extending direct antiviral agents (DAA) availability in France: an observational cohort study (2015-2019) of data from French administrative healthcare databases (SNDS).

Published:2022-02 Issue: Volume:13 Page:100281
ISSN:2666-7762
Container-title:The Lancet Regional Health - Europe
language:en
Short-container-title:The Lancet Regional Health - Europe

Author:

Pol Stanislas,Fouad Fayssoil,Lemaitre Magali,Rodriguez Ingrid,Lada Olivier,Rabiega Pascaline,Benabadji Elias,Roudot-Thoraval Françoise

Funder

Meso Scale Diagnostics

Roche

Janssen Pharmaceuticals

Gilead Sciences

Gilead Sciences Europe Ltd

Bristol-Myers Squibb

AbbVie

Publisher

Elsevier BV

Subject

Health Policy,Oncology,Internal Medicine

Reference25 articles.

1. WHO. Hepatitis C. http://www.who.int/mediacentre/factsheets/fs164/fr/ (accessed Feb 17, 2020 ).

2. Estimation de la prévalence de l'hépatite C en population générale, France métropolitaine, 2011;Pioche;Bull Epidemiol Hebd,2016

3. Course and outcome of hepatitis C;Hoofnagle;Hepatology,2002

4. Extrahepatic cancers and chronic HCV infection;Pol;Nat Rev Gastroenterol Hepatol,2018

5. History and progress of antiviral drugs: From acyclovir to direct-acting antiviral agents (DAAs) for Hepatitis C;Bryan-Marrugo;Med Univ,2015

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of HCV cure on subsequent hospitalizations in people with mental disorders: Results from the French claims database;Psychiatry Research;2024-09

2. Retrospective study of hepatitis C screening and seroprevalence in the GHU Paris;L'Encéphale;2024-09

3. Impact of pembrolizumab treatment duration on overall survival and prognostic factors in advanced non-small cell lung cancer: a nationwide retrospective cohort study;The Lancet Regional Health - Europe;2024-08

4. Association between direct acting agents used for chronic hepatitis C virus infection and the occurrence of acute leukaemia – A disproportionality analysis;Clinics and Research in Hepatology and Gastroenterology;2024-06

5. Impact of Public Policy and COVID-19 Pandemic on Hepatitis C Testing and Treatment in France, 2014–2021;Viruses;2024-05-16